Overview
- Resistance To
- rifampin, rifampicin
- Organisms
- Mycobacterium tuberculosis
- Papers
- 6
Molecular characterization of multidrug-resistant isolates of Mycobacterium tuberculosis from patients in North India.
Mutation Information
- Protein Change
- D516V
- Organisms
- Mycobacterium tuberculosis
- Confers Resistance To
- rifampin
- Source Database
- Reslit
Evaluation of the invader assay, a linear signal amplification method, for identification of mutations associated with resistance to rifampin and isoniazid in Mycobacterium tuberculosis.
Mutation Information
- Protein Change
- D516V
- Organisms
- Mycobacterium tuberculosis
- Confers Resistance To
- rifampin
- Source Database
- Reslit
Detection of rpoB mutations associated with rifampin resistance in Mycobacterium tuberculosis using denaturing gradient gel electrophoresis.
all mutations are in the rpoB gene and confer resistance to rifampin
Mutation Information
- Protein Change
- D516V
- Organisms
- Mycobacterium tuberculosis
- Confers Resistance To
- rifampin
- Source Database
- Reslit
Genetic evaluation of relationship between mutations in rpoB and resistance of Mycobacterium tuberculosis to rifampin.
Some mutations in the rpoB gene can reveal drug-resistant phenotype only in a specific genetic background of the host.
Mutation Information
- Protein Change
- D516V
- Nucleotide Change
- G516T
- Organisms
- Mycobacterium tuberculosis
- Confers Resistance To
- rifampin
- Source Database
- Reslit
Emergence and molecular characterization of extensively drug-resistant Mycobacterium tuberculosis clinical isolates from the Delhi Region in India.
Previously reported
Mutation Information
- Protein Change
- D516V
- Organisms
- Mycobacterium tuberculosis
- Confers Resistance To
- rifampin
- Source Database
- Reslit
Rapid screening of MDR-TB using molecular Line Probe Assay is feasible in Uganda.
Mutation Information
- Protein Change
- D516V
- Organisms
- Mycobacterium tuberculosis
- Confers Resistance To
- rifampicin
- Source Database
- Reslit
No comments yet. Be the first to comment!